<DOC>
	<DOCNO>NCT03082586</DOCNO>
	<brief_summary>The aim trial find maximum tolerable dose radiation deliver combined chemotherapy ( DDP &amp; Paclitaxel ) patient inoperable medically unresectable esophageal cancer .</brief_summary>
	<brief_title>Radiation Dose Escalation Esophageal Cancer</brief_title>
	<detailed_description>The RTOG 8501 establish concurrent radiochemotherapy standard care cancer esophagus.However , locoregional remain problematic , 25 % patient persistence 20 % relapse locoregional disease follow combine modality approach . New regimen urgently need improve localregional control survival .</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>1 . Histologically confirm primary squamous cell carcinoma esophagus 2 . Age 1 875 . 3 . Patients must deem unresectable disease patient deem operable due medical reason . 4 . Patients distant metastasis life expectancy &gt; /= 3 month eligible . 5 . Zubrod performance status 0 2 6 . No prior radiation thorax would overlap current treatment field . 7 . Patients nodal involvement eligible 8 . Adequate bone marrow , renal hepatic function assess follow : Hemoglobin &gt; /= 10.0 g/dl , Platelet count &gt; /= 1 00,000/mm^3 , absolute granulocyte count ( AGC ) ≥2 × 10^9 cells/L , bilirubin Aspartate transaminase ≤1.5 ×upper limit normal ( ULN ) , Creatinine &lt; /=1 .5 time ULN . 9 . A sign informed consent must obtain prior therapy . 1 0 . Induction chemotherapy allow . 1 . The presence fistula . 2 . Prior radiotherapy would overlap radiation field . 3. gastroesophageal junction cancer . 4 . Uncontrolled concurrent illness include , limited : Chronic Obstructive Pulmonary Disease ( COPD ) exacerbation respiratory illness , serious uncontrolled infection , symptomatic congestive heart failure ( CHF ) , unstable angina pectoris , uncontrolled hypertension , psychiatric illness/social situation would limit compliance study requirement . 5 . Known hypersensitivity paclitaxel . 6 . Any condition circumstance would , opinion Investigator , make patient unsuitable participation study . 7 . Acquired Immune Deficiency Syndrome . 8 . Conditions preclude medical followup protocol compliance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>